Company Overview

Company name: Sante Veritas Therapeutics
Description: Producer of medicinal cannabis intended to offer innovative and branded cannabis products and therapies. The company’s services are engaged in the production of pharma-grade, innovative, market-informed, cannabis products developed through state of the art genetics and growing environments, enabling patients to access cannabis pharmaceutical products for treatment.
Year founded: 2012
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Toronto
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 18.56
Business status: Generating Revenue
Ownership: Acquired/Merged
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by TILT Holdings through a reverse merger, resulting in the combined entity trading on the CSE stock exchange on November 21, 2018.
Number of active investors:
Profile last updated: 26-Nov-2018
Last known valuation:
Last known valuation date: